EP Patent

EP2889029A1 — Liquid formulations of bendamustine

Assigned to Cephalon LLC · Expires 2015-07-01 · 11y expired

What this patent protects

Stable liquid formulations ofbendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.

USPTO Abstract

Stable liquid formulations ofbendamustine, and pharmaceutically acceptable salts thereof, and polar aprotic solvents, are described.

Drugs covered by this patent

bendamustine-hydrochloride (BENDAMUSTINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2889029A1
Jurisdiction: EP
Classification: —
Expires: 2015-07-01
Drug substance claim: No
Drug product claim: No
Assignee: Cephalon LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.